Yusuf Tutar
Drugs that delay or destroy the novel coronavirus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), could save the lives of critically ill patients, but could also be provided prophylactically to protect healthcare workers and those at high risk of infection. Treatments will also common patients' time spent in intensive care units and free critical hospital beds.